Deutsche Bank Ag\ Uro Gen Pharma Ltd. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

A detailed history of Deutsche Bank Ag\ transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 14,289 shares of URGN stock, worth $178,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,289

Previous 13,084 9.21%

Holding current value

$178,326

Previous $196,000 21.94%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.72 - $19.2 $15,327 - $23,136	1,205 Added 9.21%	14,289 $239,000
Q1 2024 May 15, 2024	BUY	$13.81 - $19.33 $37,507 - $52,500	2,716 Added 26.2%	13,084 $196,000
Q4 2023 Feb 14, 2024	SELL	$10.87 - $15.93 $1,587 - $2,325	-146 Reduced 1.39%	10,368 $155,000
Q3 2023 Nov 09, 2023	BUY	$8.84 - $22.64 $80,824 - $206,997	9,143 Added 666.89%	10,514 $147,000
Q2 2023 Aug 14, 2023	BUY	$8.75 - $14.29 $11,996 - $19,591	1,371 New	1,371 $14,000
Q2 2022 Aug 11, 2022	SELL	$5.12 - $8.74 $57,743 - $98,569	-11,278 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.92 - $9.73 $7,459 - $12,259	-1,260 Reduced 10.05%	11,278 $98,000
Q4 2021 Feb 11, 2022	BUY	$9.03 - $19.13 $5,688 - $12,051	630 Added 5.29%	12,538 $120,000
Q3 2021 Nov 04, 2021	SELL	$14.31 - $18.39 $5,223 - $6,712	-365 Reduced 2.97%	11,908 $201,000
Q2 2021 Aug 11, 2021	SELL	$15.2 - $20.94 $14,911 - $20,542	-981 Reduced 7.4%	12,273 $188,000
Q1 2021 May 13, 2021	SELL	$17.99 - $26.96 $70,053 - $104,982	-3,894 Reduced 22.71%	13,254 $258,000
Q4 2020 Feb 16, 2021	BUY	$17.54 - $25.43 $70,931 - $102,838	4,044 Added 30.86%	17,148 $309,000
Q3 2020 Nov 12, 2020	BUY	$18.81 - $26.42 $17,719 - $24,887	942 Added 7.75%	13,104 $252,000
Q2 2020 Aug 13, 2020	BUY	$16.5 - $29.7 $91,311 - $164,359	5,534 Added 83.49%	12,162 $317,000
Q1 2020 May 14, 2020	SELL	$13.68 - $34.6 $10,136 - $25,638	-741 Reduced 10.06%	6,628 $119,000
Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $32,340 - $53,405	1,532 Added 26.25%	7,369 $244,000
Q3 2019 Nov 14, 2019	SELL	$23.83 - $36.44 $82,380 - $125,973	-3,457 Reduced 37.2%	5,837 $138,000
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $3,438 - $4,236	105 Added 1.14%	9,294 $333,000
Q1 2019 May 15, 2019	SELL	$35.47 - $54.55 $227,752 - $350,265	-6,421 Reduced 41.13%	9,189 $338,000
Q4 2018 Feb 14, 2019	SELL	$38.35 - $50.39 $267,261 - $351,167	-6,969 Reduced 30.86%	15,610 $672,000
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $437,325 - $542,850	10,500 Added 86.93%	22,579 $1.07 Million
Q2 2018 Aug 14, 2018	SELL	$48.35 - $65.33 $849,993 - $1.15 Million	-17,580 Reduced 59.27%	12,079 $601,000
Q1 2018 May 15, 2018	SELL	$38.64 - $57.54 $811,749 - $1.21 Million	-21,008 Reduced 41.46%	29,659 $1.47 Million
Q4 2017 Feb 14, 2018	BUY	$27.28 - $43.26 $935,458 - $1.48 Million	34,291 Added 209.4%	50,667 $1.89 Million
Q3 2017 Nov 14, 2017	BUY	$17.15 - $32.72 $280,848 - $535,822	16,376	16,376 $516,000

Others Institutions Holding URGN

# of Institutions

119

Shares Held

39.3M

Call Options Held

158K

Put Options Held

161K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $284M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account